Neural Regeneration Research ›› 2023, Vol. 18 ›› Issue (8): 1777-1781.doi: 10.4103/1673-5374.363179

Previous Articles     Next Articles

Inhibition of Notch 1 signaling in the subacute stage after stroke promotes striatal astrocyte-derived neurogenesis

Xiao-Zhu Hao1, Cheng-Feng Sun1, Lu-Yi Lin1, Chan-Chan Li1, Xian-Jing Zhao1, Min Jiang2, Yan-Mei Yang1, *, Zhen-Wei Yao1, *   

  1. 1Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China; 2Institutes of Science and State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China
  • Online:2023-08-15 Published:2023-02-23
  • Contact: Yan-Mei Yang, PhD, yym9876@sohu.com; Zhen-Wei Yao, PhD, aocnhnr@126.com.
  • Supported by:
    This study was supported by the National Natural Science Foundation of China, Nos. 81801660 (to XZH) and 81771788 (to YMY).

Abstract: Inhibition of Notch1 signaling has been shown to promote astrocyte-derived neurogenesis after stroke. To investigate the regulatory role of Notch1 signaling in this process, in this study, we used a rat model of stroke based on middle cerebral artery occlusion and assessed the behavior of reactive astrocytes post-stroke. We used the γ-secretase inhibitor N-[N-(3,5-diuorophenacetyl)-1-alanyl]-S-phenylglycine t-butylester (DAPT) to block Notch1 signaling at 1, 4, and 7 days after injury. Our results showed that only administration of DAPT at 4 days after stroke promoted astrocyte-derived neurogenesis, as manifested by recovery of white matter fiber bundle integrity on magnetic resonance imaging, which is consistent with recovery of neurologic function. These findings suggest that inhibition of Notch1 signaling at the subacute stage post-stroke mediates neural repair by promoting astrocyte-derived neurogenesis. 

Key words: astrocyte, diffusion kurtosis imaging, magnetic resonance imaging, middle cerebral artery occlusion, N-[N-(3,5-diuorophenacetyl)-1-alanyl]-S-phenylglycine t-butylester, neural repair, neurogenesis, neuron, Notch1 signaling, subacute stage